# The Impact of an Epidural Anesthetic on the Consumption of Sevoflurane in Major Abdominal Surgery

> **NCT04021264** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **University of Alberta**

## Conditions studied

- Bowel Disease
- Liver Diseases
- Pancreas Disease
- Anesthesia; Functional

## Interventions

- **DRUG:** Ropivacaine-Sufentanil
- **DRUG:** Dextrose 5

## Key facts

- **NCT ID:** NCT04021264
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-08-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Inability to enroll participants.
- **Last updated:** 2022-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04021264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04021264, "The Impact of an Epidural Anesthetic on the Consumption of Sevoflurane in Major Abdominal Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04021264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*